# Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

> **NCT05731258** · — · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer
- Liposomal Doxorubicin
- Efficacy
- Safety
- Postoperative Adjuvant Treatment

## Interventions

- **DRUG:** Liposomal doxorubicin containing regimen

## Key facts

- **NCT ID:** NCT05731258
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-01
- **Primary completion:** 2027-10
- **Final completion:** 2032-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05731258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05731258, "Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05731258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*